DE60233949D1 - Diagnostische marker für schlaganfall und hirntrauma sowie verfahren zur verwendung davon - Google Patents

Diagnostische marker für schlaganfall und hirntrauma sowie verfahren zur verwendung davon

Info

Publication number
DE60233949D1
DE60233949D1 DE60233949T DE60233949T DE60233949D1 DE 60233949 D1 DE60233949 D1 DE 60233949D1 DE 60233949 T DE60233949 T DE 60233949T DE 60233949 T DE60233949 T DE 60233949T DE 60233949 D1 DE60233949 D1 DE 60233949D1
Authority
DE
Germany
Prior art keywords
stroke
markers
diagnosis
patient
analyzed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60233949T
Other languages
English (en)
Inventor
Gunars E Valkirs
Jeffrey R Dahlen
Kenneth F Buechler
Howard J Kirchick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alere San Diego Inc
Original Assignee
Biosite Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosite Inc filed Critical Biosite Inc
Application granted granted Critical
Publication of DE60233949D1 publication Critical patent/DE60233949D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2871—Cerebrovascular disorders, e.g. stroke, cerebral infarct, cerebral haemorrhage, transient ischemic event
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE60233949T 2001-08-20 2002-08-20 Diagnostische marker für schlaganfall und hirntrauma sowie verfahren zur verwendung davon Expired - Lifetime DE60233949D1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US31377501P 2001-08-20 2001-08-20
US33496401P 2001-11-30 2001-11-30
US34648502P 2002-01-02 2002-01-02
PCT/US2002/026604 WO2003016910A1 (en) 2001-08-20 2002-08-20 Diagnostic markers of stroke and cerebral injury and methods of use thereof

Publications (1)

Publication Number Publication Date
DE60233949D1 true DE60233949D1 (de) 2009-11-19

Family

ID=27405676

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60233949T Expired - Lifetime DE60233949D1 (de) 2001-08-20 2002-08-20 Diagnostische marker für schlaganfall und hirntrauma sowie verfahren zur verwendung davon

Country Status (7)

Country Link
US (1) US7427490B2 (de)
EP (1) EP1419388B1 (de)
JP (1) JP2005522669A (de)
AT (1) ATE445160T1 (de)
CA (1) CA2457775A1 (de)
DE (1) DE60233949D1 (de)
WO (1) WO2003016910A1 (de)

Families Citing this family (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6627404B1 (en) * 1995-04-18 2003-09-30 Biosite, Inc. Methods for improving the recovery of troponin I and T in membranes, filters and vessels
US6991907B1 (en) 1995-04-18 2006-01-31 Biosite, Inc. Methods for the assay of troponin I and T and complexes of troponin I and T and selection of antibodies for use in immunoassays
US6780606B1 (en) 1999-02-26 2004-08-24 Synx Pharma, Inc. Method for diagnosing and distinguishing stroke and diagnostic devices for use therein
CA2263063C (en) * 1999-02-26 2004-08-10 Skye Pharmatech Incorporated Method for diagnosing and distinguishing stroke and diagnostic devices for use therein
US7927784B2 (en) 2000-12-20 2011-04-19 Ev3 Vascular lumen debulking catheters and methods
US20030199000A1 (en) * 2001-08-20 2003-10-23 Valkirs Gunars E. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US7713705B2 (en) * 2002-12-24 2010-05-11 Biosite, Inc. Markers for differential diagnosis and methods of use thereof
US7632647B2 (en) * 2001-04-13 2009-12-15 Biosite Incorporated Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes
US20040176914A1 (en) * 2001-04-13 2004-09-09 Biosite Incorporated Methods and compositions for measuring biologically active natriuretic peptides and for improving their therapeutic potential
US7524635B2 (en) * 2003-04-17 2009-04-28 Biosite Incorporated Methods and compositions for measuring natriuretic peptides and uses thereof
US20040253637A1 (en) * 2001-04-13 2004-12-16 Biosite Incorporated Markers for differential diagnosis and methods of use thereof
US7608406B2 (en) * 2001-08-20 2009-10-27 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20040209307A1 (en) * 2001-08-20 2004-10-21 Biosite Incorporated Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20040219509A1 (en) * 2001-08-20 2004-11-04 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20030040660A1 (en) * 2001-08-27 2003-02-27 George Jackowski Method for diagnosing and distinguishing traumatic brain injury and diagnostic devices for use therein
CA2511501A1 (en) * 2002-12-24 2004-07-15 Biosite Incorporated Markers for differential diagnosis and methods of use thereof
WO2005037286A1 (en) * 2003-03-25 2005-04-28 Vasopharm Biotech Gmbh Use of pteridine derivatives for the treatment of increased intracranial pressure and secondary ischemia
US7341838B2 (en) * 2003-04-17 2008-03-11 Biosite Incorporated Polypeptides related to natriuretic peptides and methods of their identification and use
WO2004105575A2 (en) * 2003-05-29 2004-12-09 Trustee Of Darmouth College A method for detecting cardiac ischemia via changes in b-natriuretic peptide levels
GB2404981A (en) * 2003-08-15 2005-02-16 Univ Geneve Diagnostic method for stroke
EP1664795B1 (de) * 2003-09-20 2017-11-08 Electrophoretics Limited Diagnoseverfahren für erkrankungen im zusammenhang mit hirnschäden
EP1519194A1 (de) 2003-09-24 2005-03-30 Roche Diagnostics GmbH Die Verwendung von GFAP zur Identifizierung einer Intrazerebralblutung
WO2005033327A2 (en) * 2003-09-29 2005-04-14 Biosite Incorporated Methods and compositions for the diagnosis of sepsis
CN1316037C (zh) * 2003-12-19 2007-05-16 叶尚勉 检测待测标本中生存素表达量的诊断试剂、检测方法及应用
EP1562046A1 (de) * 2004-02-03 2005-08-10 B.R.A.H.M.S Aktiengesellschaft Diagnose von Sepsis durch selektive Bestimmung der Konzentration der Cu/Zn Superoxiddismutase (Cu/Zn SOD) in Patientenproben
US8492107B2 (en) 2004-04-15 2013-07-23 University Of Florida Research Foundation, Inc. Neural proteins as biomarkers for nervous system injury and other neural disorders
US7300494B2 (en) * 2005-02-24 2007-11-27 Hamilton Sundstrand Corporation On-board inert gas generation system with compressor surge protection
US7794413B2 (en) 2005-04-19 2010-09-14 Ev3, Inc. Libraries and data structures of materials removed by debulking catheters
US20070099239A1 (en) * 2005-06-24 2007-05-03 Raymond Tabibiazar Methods and compositions for diagnosis and monitoring of atherosclerotic cardiovascular disease
US20070038173A1 (en) * 2005-07-27 2007-02-15 Fox Hollow Technologies, Inc. Methods affecting markers in patients having vascular disease
EP1929295A4 (de) * 2005-08-30 2010-03-17 Biosite Inc Verwendung von löslichem flt-1 und seiner fragmente bei herz-kreislauf-leiden
US7807378B2 (en) * 2005-12-29 2010-10-05 Industrial Technology Research Institute (Itri) Method of diagnosing myasthenia gravis and kits therefor
US7989207B2 (en) 2006-02-17 2011-08-02 Tyco Healthcare Group Lp Testing lumenectomy samples for markers of non-vascular diseases
US20070224643A1 (en) * 2006-03-09 2007-09-27 Mcpherson Paul H Methods and compositions for the diagnosis of diseases of the aorta
US20080118924A1 (en) * 2006-05-26 2008-05-22 Buechler Kenneth F Use of natriuretic peptides as diagnostic and prognostic indicators in vascular diseases
WO2008008846A2 (en) * 2006-07-11 2008-01-17 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Differential expression of molecules associated with intra-cerebral hemorrhage
EP2095107B1 (de) 2006-11-14 2014-07-02 Alere San Diego, Inc. Verfahren zur risikoabschätzung
WO2008061149A2 (en) * 2006-11-14 2008-05-22 Biosite Incorporated Methods and compositions for diagnosis and prognosis of renal artery stenosis
SE532103C2 (sv) 2006-12-12 2009-10-27 Knut Johansen Metod för att bestämma hälsostatus från analyter i vätskeprover
US8221995B2 (en) 2007-03-23 2012-07-17 Seok-Won Lee Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
EP2152907A1 (de) 2007-05-01 2010-02-17 The Regents of the University of California Verfahren zur diagnose von ischämie
JP5339227B2 (ja) 2007-05-18 2013-11-13 国立大学法人 千葉大学 アクロレイン、インターロイキン−６及びｃｒｐの含有量、ポリアミンオキシダーゼ活性又はポリアミンオキシダーゼの蛋白質量、並びに、被験者の年齢を指標とした脳卒中・無症候性脳梗塞の検出方法
KR100956764B1 (ko) * 2007-11-27 2010-05-12 한국 한의학 연구원 헤모글로빈-알파 서브유닛을 바이오 마커로 이용한 뇌졸중진단방법
WO2009075863A2 (en) * 2007-12-11 2009-06-18 New York University School Of Medicine Method for diagnosing stroke
EP2238455A4 (de) * 2008-01-18 2011-03-02 Vatrix Medical Inc Diagnostische biomarker für gefässaneurysma
KR101110758B1 (ko) 2008-06-02 2012-02-15 경북대학교 산학협력단 뇌졸중 표적용 펩티드 및 이의 용도
CA2733990C (en) * 2008-08-11 2018-12-11 Banyan Biomarkers, Inc. Biomarker detection process and assay of neurological condition
JP2011530705A (ja) * 2008-08-13 2011-12-22 エフ．ホフマン−ラ ロシュ アーゲー 肺塞栓症のためのＤダイマー、トロポニン、ＮＴ−ｐｒｏＢＮＰ
JP5902479B2 (ja) * 2008-10-24 2016-04-13 ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング マーカーペプチドのレベルを決定することによる脳卒中患者における予後判定及びリスク評価のための方法
WO2010086697A1 (en) * 2009-01-30 2010-08-05 Bio-Rad Pasteur Method for the in vitro diagnosis of stroke
WO2010096331A1 (en) 2009-02-11 2010-08-26 Duke University Sensors incorporating antibodies and methods of making and using the same
CN101825627B (zh) * 2009-03-02 2013-10-02 江苏迈迪基因生物科技有限公司 心力衰竭的生物标志物的联合并行检测方法及诊断试剂盒
JP5747370B2 (ja) 2009-03-31 2015-07-15 国立大学法人浜松医科大学 高病原性口腔細菌の高感度検出法
DK2419741T3 (da) 2009-04-14 2019-11-04 Brahms Gmbh Risikovurdering af antibiotikabehandling af patienter, der lider af primær ikke-infektiøs sygdom, ved bestemmelse af niveauet af procalcitonin
US20100312139A1 (en) * 2009-06-04 2010-12-09 Board Of Regents Of The University Of Texas System Method for Identifying Mammals at Risk for Elevated intracranial Pressure
WO2010148391A2 (en) * 2009-06-19 2010-12-23 Banyan Biomarkers, Inc. Biomarker assay of neurological condition
JP5795256B2 (ja) * 2009-07-31 2015-10-14 バイオ−ラッド・イノベーションズＢｉｏ−Ｒａｄ Ｉｎｎｏｖａｔｉｏｎｓ 卒中のインビトロ診断のための方法
EP2462444B1 (de) * 2009-08-07 2018-10-03 Affinimark Technologies, Inc. Verfahren zur immunologischen identifikation einer liquor-flüssigkeit
US20130022982A1 (en) 2009-09-14 2013-01-24 Kevin Ka-Wang Wang Micro-rna, autoantibody and protein markers for diagnosis of neuronal injury
EP2499489B1 (de) 2009-11-13 2015-01-07 BG Medicine, Inc. Risikofaktoren und vorhersage von myokardinfarkt
WO2011062738A1 (en) 2009-11-23 2011-05-26 Mikhail Briman Controlled electrochemical activation of carbon-based electrodes
JP2011206049A (ja) * 2010-03-08 2011-10-20 Sumio Sugano 壊死マーカー及びその用途
WO2011143412A1 (en) * 2010-05-14 2011-11-17 University Of Connecticut Methods for the detection and monitoring of acute myocardial infarction
WO2011160096A2 (en) * 2010-06-17 2011-12-22 Banyan Biomarkers, Inc. Glial fibrillary acidic protein, autoantigens and autoantibodies thereto as biomarkers of neural injury or neurological disorder or condition
EP2593566B1 (de) * 2010-07-14 2018-01-24 The Regents of The University of California Biomarker zur diagnose transitorischer ischämischer attacken
CN103080339B (zh) 2010-07-15 2016-08-31 加利福尼亚大学董事会 用于诊断卒中及其致因的生物标志物
JP6071886B2 (ja) * 2010-10-14 2017-02-01 ザ・ジョンズ・ホプキンス・ユニバーシティ 脳損傷のバイオマーカー
WO2012121978A2 (en) 2011-03-04 2012-09-13 The Regents Of The University Of California Biomarkers for the diagnosis of lacunar stroke
US20140141458A1 (en) 2011-05-12 2014-05-22 The Johns Hopkins University Assay reagents for a neurogranin diagnostic kit
JP5833755B2 (ja) 2011-07-25 2015-12-16 ブリマン、ミカイル 診断試験用カートリッジ
CA2850366A1 (en) * 2011-09-30 2013-04-04 The Research Institute At Nationwide Children's Hospital Compositions and methods for detection of defensins in a patient sample
ES2595028T3 (es) 2011-10-17 2016-12-27 F. Hoffmann-La Roche Ag Diagnóstico basado en Troponina y BNP de pacientes en riesgo y causa de ictus
EP2786154B1 (de) 2011-12-01 2017-11-01 Roche Diagnostics GmbH Nt-pro-anp und nt-pro-bnp zur diagnose eines schlaganfalls
GB2497138A (en) * 2011-12-02 2013-06-05 Randox Lab Ltd Biomarkers for stroke and stroke subtype diagnosis.
CN103163295B (zh) * 2011-12-08 2015-11-18 吴宗贵 一种用于急性冠脉综合征的液相芯片试剂盒以其制备方法
WO2013103781A1 (en) 2012-01-07 2013-07-11 The Regents Of The University Of California Biomarkers for diagnosing ischemia
US20130244892A1 (en) * 2012-02-12 2013-09-19 Aram S. Adourian Risk Factors and Prediction of Adverse Events
CN103308673B (zh) * 2012-03-08 2017-05-31 思芬构技术有限公司 用于预测雌性对象中发生心血管事件的风险的方法
WO2013138509A1 (en) 2012-03-13 2013-09-19 The Johns Hopkins University Citrullinated brain and neurological proteins as biomarkers of brain injury or neurodegeneration
WO2014110674A1 (en) * 2013-01-15 2014-07-24 University Of Manitoba Biomarkers for rapid detection of an occurrence of a stroke event
GB201309928D0 (en) 2013-06-04 2013-07-17 Randox Lab Ltd Method
EP3757226A3 (de) 2013-07-17 2021-05-05 The Johns Hopkins University Multiprotein-biomarkertest für den nachweis von hirnläsionen und ergebnis
JP6353837B2 (ja) * 2013-08-05 2018-07-04 第一三共株式会社 肝障害のタイプの検査方法
US10407716B2 (en) 2014-03-13 2019-09-10 Duke University Electronic platform for sensing and control of electrochemical reactions
EP3029466A1 (de) 2014-12-03 2016-06-08 Fundació Hospital Universitari Vall d' Hebron - Institut de Recerca Verfahren zur Unterscheidung eines ischämischen Schlaganfalls von einem hämorrhagischem Schlaganfall
GB201619823D0 (en) 2016-11-23 2017-01-04 Randox Laboratories Ltd And Teoranta Randox GFAP accumulating stroke
CN110709704A (zh) * 2017-05-30 2020-01-17 雅培实验室 利用心肌肌钙蛋白i辅助诊断和评估人类受试者的轻度创伤性脑损伤的方法
WO2019018545A1 (en) 2017-07-18 2019-01-24 The Research Foundation For The State University Of New York BIOMARKERS OF INTRACRANIAL ANEVISM
CN107368708B (zh) * 2017-08-14 2018-03-16 东莞博奥木华基因科技有限公司 一种精准分析dmd基因结构变异断点的方法及***
JP2021503610A (ja) * 2017-11-16 2021-02-12 ブレインボックス ソルーションズ、インコーポレイテッドＢｒａｉｎｂｏｘ Ｓｏｌｕｔｉｏｎｓ， Ｉｎｃ． 神経損傷および／または疾患のタンパク質バイオマーカー指標及びその使用の方法
WO2019115620A1 (en) * 2017-12-13 2019-06-20 Roche Diagnostics Gmbh Circulating angiopoietin-2 (ang-2) and insulin-like growth factor-binding protein 7 (igfbp7) for the prediction of stroke
WO2020053881A1 (en) * 2018-09-10 2020-03-19 Indian Institute Of Technology Bombay A device to detect stroke
US11406681B2 (en) 2019-12-23 2022-08-09 Hemopet Compound for treating oxidative stress in mammals
US10989717B1 (en) * 2019-12-23 2021-04-27 Hemopet Oxidative stress biomarkers testing in animals
US11181538B2 (en) 2019-12-23 2021-11-23 Hemopet Oxidative stress biomarkers testing in canines
US11596663B2 (en) 2019-12-23 2023-03-07 Hemopet Compound for treating oxidative stress in canines
ES2922403B2 (es) * 2021-03-03 2023-12-11 Fundacion Para La Investigacion Biomedica Del Hospital Univ La Paz Fibhulp Biomarcadores para el pronóstico de pacientes que han sufrido una hemorragia subaracnoidea aneurismática (SAH)

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4447545A (en) 1980-11-03 1984-05-08 New England Deaconess Hospital Bladder cancer detection
US5350842A (en) 1986-09-30 1994-09-27 Board Of Regents, The University Of Texas System DNAs encoding Treponema pallidum antigens
US5114923A (en) 1988-05-31 1992-05-19 California Biotechnology Inc. Recombinant techniques for production of novel natriuretic and vasodilator peptides
US5422393A (en) 1988-07-11 1995-06-06 Naturon Pharmaceutical Corporation Natriuretic hormone
US5028535A (en) 1989-01-10 1991-07-02 Biosite Diagnostics, Inc. Threshold ligand-receptor assay
US5939272A (en) 1989-01-10 1999-08-17 Biosite Diagnostics Incorporated Non-competitive threshold ligand-receptor assays
WO1990010870A1 (en) 1989-03-01 1990-09-20 Cornell Research Foundation, Inc. Development of a monoclonal antibody based detection system for listeria monocytogenes
JP3394040B2 (ja) 1989-06-23 2003-04-07 ジェネンテック・インコーポレーテッド ナトリウム***増加性蛋白質受容体ｂの組成物および合成法および使用法
US5922615A (en) 1990-03-12 1999-07-13 Biosite Diagnostics Incorporated Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network
CA2072758A1 (en) 1990-09-14 1992-03-15 Kenneth Francis Buechler Antibodies to complexes of ligand receptors and ligands and their utility in ligand-receptor assays
CA2027434C (en) 1990-10-12 1999-01-05 George Jackowski Diagnostic kit for diagnosing and distinguishing chest pain in early onset thereof
US5604105B1 (en) * 1990-10-12 1999-08-24 Spectral Diagnostics Inc Method and device for diagnosingand distinguishing chest pain in early onset thereof
US5955377A (en) 1991-02-11 1999-09-21 Biostar, Inc. Methods and kits for the amplification of thin film based assays
DE69228682T2 (de) 1991-04-10 1999-07-01 Biosite Diagnostics Inc "crosstalk"- oder übersprech-inhibitoren und ihre verwendung
EP0579767B1 (de) 1991-04-11 2000-08-23 Biosite Diagnostics Inc. Neue konjugate und testverfahren für die gleichzeitige bestimmung von multiplen liganden
US6143576A (en) 1992-05-21 2000-11-07 Biosite Diagnostics, Inc. Non-porous diagnostic devices for the controlled movement of reagents
US6019944A (en) 1992-05-21 2000-02-01 Biosite Diagnostics, Inc. Diagnostic devices and apparatus for the controlled movement of reagents without membranes
GB9211686D0 (en) 1992-06-03 1992-07-15 Medisinsk Innovation A S Chemical compounds
US5494829A (en) 1992-07-31 1996-02-27 Biostar, Inc. Devices and methods for detection of an analyte based upon light interference
US5482935A (en) 1993-01-05 1996-01-09 American Home Product Corporation Anti-atherosclerotic use of 17 alpha-dihydroequilin
US5824799A (en) 1993-09-24 1998-10-20 Biosite Diagnostics Incorporated Hybrid phthalocyanine derivatives and their uses
US6538121B1 (en) 1994-11-01 2003-03-25 Human Genome Sciences, Inc. Interleukin-1 β converting enzyme like apoptosis protease-3 and 4
TW343990B (en) * 1996-02-09 1998-11-01 Nippon Kayaku Kk Epoxy resin, epoxy resin composition and hardened product thereof
EP1557431B1 (de) 1996-03-04 2012-08-15 Scios Inc. Testverfahren und Reagenzien zur Quantifizierung von hbnp
US5645995A (en) 1996-04-12 1997-07-08 Baylor College Of Medicine Methods for diagnosing an increased risk for breast or ovarian cancer
US5690103A (en) 1996-06-20 1997-11-25 Groth; Torgny Lars Detection/exclusion of acute myocardial infarction using neural network analysis of measurements of biochemical markers
HUP0102907A1 (hu) 1996-09-20 2004-05-28 Atherogenics Inc. Gyulladásos rendellenességek diagnosztizálása és mediátorai
US6113855A (en) 1996-11-15 2000-09-05 Biosite Diagnostics, Inc. Devices comprising multiple capillarity inducing surfaces
US5947124A (en) 1997-03-11 1999-09-07 Biosite Diagnostics Incorporated Diagnostic for determining the time of a heart attack
EP0869393B1 (de) 1997-03-31 2000-05-31 Fuji Photo Film Co., Ltd. Positiv-arbeitende photoempfindliche Zusammensetzung
US6057098A (en) 1997-04-04 2000-05-02 Biosite Diagnostics, Inc. Polyvalent display libraries
ATE315228T1 (de) 1997-09-11 2006-02-15 Shionogi & Co Immunoassay zum bestimmen von bnp
WO1999018442A1 (en) * 1997-10-07 1999-04-15 Centocor, Inc. Diagnosis of thrombotic events by detecting p-selectin
US6099469A (en) 1998-06-02 2000-08-08 Armstrong; E. Glenn Reflex algorithm for early and cost effective diagnosis of myocardial infractions suitable for automated diagnostic platforms
US6117644A (en) 1998-06-04 2000-09-12 Ottawa Heart Institute Research Corporation Predicting and detecting cardiac allograft rejection
US6309888B1 (en) 1998-09-04 2001-10-30 Leuven Research & Development Vzw Detection and determination of the stages of coronary artery disease
CA2343975A1 (en) 1998-09-29 2000-04-06 Lars Christian Ronn Ncam binding compounds
CA2263063C (en) 1999-02-26 2004-08-10 Skye Pharmatech Incorporated Method for diagnosing and distinguishing stroke and diagnostic devices for use therein
AT407580B (de) 1999-08-20 2001-04-25 Biomedica Gmbh Indikatorpeptid zur diagnose und/oder vorhersage von cardiovasculären und/oder endothelialen erkrankungen, antikörperzusammensetzung und immunoassay
US6268223B1 (en) 1999-08-27 2001-07-31 Viatech Imagin, Llc Assay for detecting damage to the central nervous system
DE60043531D1 (de) 1999-09-02 2010-01-28 Asahi Glass Co Ltd Optischer kopf
GB9929140D0 (en) 1999-12-10 2000-02-02 Univ Geneve Diagnostic assay for stroke
US6443889B1 (en) 2000-02-10 2002-09-03 Torgny Groth Provision of decision support for acute myocardial infarction
AU2001268233A1 (en) 2000-06-08 2001-12-17 Chiron Corporation Compositions and methods for treating neoplastic disease using inhibitors of laminin5beta3
AUPR005600A0 (en) * 2000-09-12 2000-10-05 University Of Sydney, The Diagnostic assay
US6670138B2 (en) * 2000-11-01 2003-12-30 Agy Therapeutics, Inc. Method of diagnosing ischemic stroke via UCP-2 detection
US20020106708A1 (en) 2000-11-13 2002-08-08 Sigma-Aldrich Co. Assays reagents and kits for detecting or determining the concentration of analytes
US20040072805A1 (en) 2001-04-06 2004-04-15 Warren Marshelle S. Use of tumor necrosis factor inhibitors to treat cardiovascular disease
US7632647B2 (en) 2001-04-13 2009-12-15 Biosite Incorporated Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes
AU2002305394A1 (en) 2001-05-04 2002-11-18 Biosite, Inc. Diagnostic markers of acute coronary syndromes and methods of use thereof
ATE370943T1 (de) 2001-06-27 2007-09-15 Smithkline Beecham Corp Fluoropyrrolidine als dipeptidyl-peptidase inhibitoren
EP1399420B1 (de) 2001-06-27 2007-12-05 SmithKline Beecham Corporation Pyrrolidine als dipeptidyl peptidase inhibitoren
US6627457B2 (en) * 2001-07-30 2003-09-30 Quest Diagnostics Investments Incorporated Methods for detecting pregnancy
AUPS169202A0 (en) 2002-04-11 2002-05-16 Goetze, Jens Peter Neuropeptide assay
US20050181386A1 (en) 2003-09-23 2005-08-18 Cornelius Diamond Diagnostic markers of cardiovascular illness and methods of use thereof

Also Published As

Publication number Publication date
EP1419388A4 (de) 2006-02-15
US7427490B2 (en) 2008-09-23
WO2003016910A1 (en) 2003-02-27
EP1419388B1 (de) 2009-10-07
ATE445160T1 (de) 2009-10-15
EP1419388A1 (de) 2004-05-19
US20030119064A1 (en) 2003-06-26
CA2457775A1 (en) 2003-02-27
JP2005522669A (ja) 2005-07-28

Similar Documents

Publication Publication Date Title
DE60233949D1 (de) Diagnostische marker für schlaganfall und hirntrauma sowie verfahren zur verwendung davon
US10866248B2 (en) Methods and materials for monitoring myeloma using quantitative mass spectrometry
WO2006036220A3 (en) Cellular fibronectin as a diagnostic marker in stroke and methods of use thereof
WO2002089657A3 (en) Diagnostic markers of acute coronary syndromes and methods of use thereof
WO2004046729A3 (en) Bodily fluid markers of tissue hypoxia
DE60239470D1 (de) Verfahren zur bewertung pathologischer krankheitszustände unter verwendung extrazellulärer rna
ATE440151T1 (de) Verfahren zur beurteilung eines krankheitzustandes mittels nachweis von partikel- und nicht partikelgebundenen nukleinsäuren in blutplasma und -serum
DE602005011008D1 (de) Verwendung der Gene Kir2.3 und DRD2 als molekulare Marker zur Diagnose von Schizophrenie
DE60223561D1 (de) Verfahren zum nachweis von oxidativem stress sowie kit zur durchführung davon
ATE423217T1 (de) Assays zur überwachung von krebspatienten auf grundlage der spiegel von analytenkomponenten des plasminogen-aktivator-systems in proben von körperflüssigkeiten
ATE365922T1 (de) Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6)
WO2006113210A3 (en) Diagnostic multimarker serological profiling
DE69939121D1 (de) Verfahren und materialien zum nachweis und zur messung von durch freie radikale verursachten schäden
ATE476525T1 (de) Verfahren zum nachweis von mit endometrialer krankheit oder phase assoziierten markern
DE60332538D1 (de) Oligosaccharid-biomarker für mucopolysaccharidosen und andere verwandte störungen
WO2007015113A3 (en) New protein isoforms of the pif-family and uses thereof
IL142971A0 (en) S100 proteins and autoantibodies as serum markers for cancer
ATE418072T1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
BRPI0412110A (pt) genes regulados no cáncer ovariano como alvos prognósticos e terapêuticos
ATE314648T1 (de) Diagnostisches verfahren für asthma
WO2007071829A3 (en) Methods and means related to diseases
DE602005023329D1 (de) VERFAHREN ZUR DIAGNOSE NICHT-KLEINZELLIGER LUNGENKARZINOME ÜBER DIE tRNA-DIHYDROURIDIN-SYNTHASEAKTIVITÄT VON URLC8
BRPI0413332A (pt) dispositivo e processo para avaliação quantitativa dos polipetìdeos contidos em uma amostra de fluido corporal bem como marcadores para identificação de estados patológicos
RU2011150291A (ru) Фосфодиэстераза-9а в качестве маркера злокачественной опухоли предстательной железы
DE602004017317D1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome

Legal Events

Date Code Title Description
8364 No opposition during term of opposition